Thursday, February 04, 2021

#Solar #Stocks seeing #Green in 2021: (OTCQB: $SING) (NYSE: $JKS) (NASDAQ: $CSIQ) (NASDAQ: $FSLR) (NASDAQ: $SEDG) (NASDAQ: $ENPH) @_Singlepoint_; @JinkoSolarCoLtd; @Canadian_Solar; @FirstSolar; @SolarEdgePV; @Enphase

#Solar #Stocks seeing #Green in 2021: (OTCQB: $SING) (NYSE: $JKS) (NASDAQ: $CSIQ) (NASDAQ: $FSLR) (NASDAQ: $SEDG) (NASDAQ: $ENPH) @_Singlepoint_; @JinkoSolarCoLtd; @Canadian_Solar; @FirstSolar; @SolarEdgePV; @Enphase

 

SinglePoint (OTCQB: $SING) Completes Acquisition of Premier Solar Lead Generation Engine, EnergyWyze, LLC

 

Point Roberts WA, Delta BC, February 4, 2021 – Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks (Renewableenergystocks.com) issue a sector snapshot on solar stocks featuring SinglePoint, Inc. (OTCQB:SING), a company focused on providing renewable energy solutions.

 

As a new era for renewable energy unfolds under a Biden administration, companies in the sector will add to the momentum that has been building for months. 

 

Read this article featuring SING in full at https://www.investorideas.com/news/2021/cleantech-climatechange/02041Solar-Stocks.asp

 

According to Trading Platforms Justinas Baltrusaitis, “Solar energy stocks have recorded significant growth in the last few months, boosted by factors like regulatory changes. These stocks’ growth is reflected in the Return on Investments for the selected leading solar energy companies.”

 

“Data presented by Trading Platforms indicates that four leading solar energy stocks have recorded an average ROI of 135.2% over the last six months between July 27, 2020 and January 27, 2021. JinkoSolar Holding (NYSE: JKS) has the highest ROI at 264.12%.

Canadian Solar (NASDAQ: CSIQ) registered the second-highest returns of 138.21%, followed by First Solar (NASDAQ: FSLR) which has an ROI of 72.55%. SolarEdge Technologies (NASDAQ: SEDG) has recorded an ROI of 65.95%.”

 

SinglePoint, Inc. (OTCQB: SING) has experienced some of its biggest gains in 2021 and some of the largest trading volumes in the stock’s history as investor interest in solar stocks surged.

 

Following its strategic path of building a renewable energy solutions portfolio, it announced yesterday it has completed the acquisition of EnergyWyze, LLC which was initially announced on January 12, 2021. With the transaction complete, SinglePoint bolsters its digital and direct marketing assets and business relationships that will streamline, optimize and maximize its customer-centric lead generation, including an extensive database of validated leads, to form a preeminent solar lead generation engine.

 

“We are extremely excited to add the assets and expertise of EnergyWyze to the SinglePoint team and business. Closing this transaction further expands our lead generation capabilities, maximizes our overall online presence, and enhances the value of all our solar subsidiaries. We look forward to leveraging this next-generation lead generation platform and network that will ultimately drive significant growth and propel SinglePoint to the next level in the near term,” commented Wil Ralston, President of SinglePoint.

 

From the news: EnergyWyze transforms the solar installation experience for both homeowners and contractors. The Company is led by a group of experts with deep history in acquiring and developing solar leads for some of the nation’s largest solar companies including Vivint Solar, SunEdison, Crius Solar, Radix and more.

 

From the news: It is estimated that less than 4% of the residential solar addressable market in the domestic U.S. market currently has a solar system installed. Customer acquisition can account for a significant percentage of the spend in solar contractors' cost of doing business. With this newly formed premier lead generation engine, SinglePoint aims to reduce those costs and increase the conversion rate of new customers through creating a premium customer experience the solar industry is lacking at this point in time.

 

From the news: With its initial focus in solar energy, the Company is building a foundation for future expansion opportunities including energy storage, charge points for electric vehicles and solar as a subscription.

 

Looking forward, the Company issued news on January 20th with an updated presentation of its vision for renewable energy.      

 

From the news: "2021 is poised to be a transformational year for SinglePoint. Our team continues to build momentum and execute on the strategic objectives set out in front of us, including but not limited to, uplisting to a national exchange, establishing a leadership position in the renewable energy sector, and driving shareholder value and long-term growth. As we continue to move forward, we are fully committed to raising awareness of SinglePoint in the investment community and executing a fundamental, strategic investor relations program. We are grateful for the continued support of our shareholders and remain excited about the future of SinglePoint," commented Wil Ralston, President of SinglePoint.

 

According to an Infographic Kryptoszene.de, “The relative search volume on Google for the search term pair "solar shares" rose by 1,328% in the first week of January compared to the same period last year. A look at relevant listed companies' share price performance reveals that investors are not content to merely gather information. For example, the price of Enphase Energy (NASDAQ: ENPH) shares rose by 478% in a 12-month review, while the DAX gained only 2.2%. “

 

In late January Enphase Energy (NASDAQ: ENPH) announced the closing of its acquisition of Sofdesk Inc., headquartered in Montreal, Canada. Sofdesk’s Solargraf™ integrated software platform offers the industry’s leading digital tools and services designed to simplify and accelerate the end-to-end sales process across the residential solar industry.

 

From the news: The Solargraf platform provides solar installers with critical pre-sales engagement design, quoting and work-flow management from any PC, tablet or mobile device. In addition, Sofdesk also offers Roofgraf™, a software product that enables roofing contractors to generate homeowner proposals using advanced machine learning technology.

“This acquisition supercharges Enphase’s digital transformation efforts,” said Jayant Somani, Vice President of digital transformation at Enphase Energy. “With these tools, residential installers can drive the industry towards better customer journeys, create happier customers, and help accelerate the transition to clean energy.”

 

Going into 2021 investor interest in solar stocks spiked and now as Biden and other world leaders lay out plans for the future, only time will tell how investors will react long term.

 

For investors following renewable energy and solar stocks, visit the directory of publicly traded stocks https://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp

 

Visit the Cleantech and Climate Change Podcast page at Investorideas.com

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this article featuring SING is paid for content on investorideas.com (2000)  More disclaimer and disclosure info.  Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Contact Investorideas.com

800 665 0411

 


RenewableEnergyStocks.com: investing ideas in renewable energy stocks - solar, wind, batteries and more - Environmental, social and governance (ESG) investing tools

Like Renewable Energy Stocks? View our Renewable Energy Stocks Directory

 

 

 

#Telemedicine #Stock News: GBT (OTCPINK: $GTCH) Developing a Long-Range Radio System Targeting Global Communication for Remote Telemedicine

 #Telemedicine #Stock News: GBT (OTCPINK: $GTCH) Developing a Long-Range Radio System Targeting Global Communication for Remote Telemedicine

 


SAN DIEGO, February 4, 2021 (Investoridea.com Newswire) - GBT Technologies Inc. (OTCPINK: GTCH) ("GBT” or the “Company”), commenced the development of a long range radio system targeting global communication for remote telemedicine.  GBT believes that the system, if fully developed, can be used for a wide variety of applications in the military, science research, global maritime telemedicine, remote hiking communication and similar.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/02041Radio-System-Remote-Telemedicine.asp

 

GBT’s vision is to enable telemedicine services around our globe. Starting with its qTerm vitals device and moving forward towards new infrastructure for health monitoring technological services, the company is now seeking to develop a long-range radio system to enable health monitoring anywhere in the world. The long-range radio system will be developed based on GBT’s granted patent #10,616,715, which presents an ultra-long-range radio system for tracking technology. The new radio system is being developed to work with qTerm and the company’s future health related technology to enable data and audio communication for long distances. Providing health services is challenging in remote locations around the world. The introduced system, is aiming to enable telemedicine services where conventional communication is not available, for example, remote mountains, jungles, maritime vessels and similar. In remote locations an immediate health related vitals and information may be needed to be sent to a faraway physician for a quick advice. It is the goal of the radio system to enable sending data and audio signals thousands of miles reaching a physician in a modern clinic. For example, a user will be able to take his/her vitals using qTerm device in a village, somewhere near the Amazon river, and sending it for a quick physician evaluation in San Diego, California. The radio system is targeted bidirectional data and audio communication for first phase. The second phase is planned to include a wider bandwidth to support live video streaming. The company believes that this type of technology can assist with global health in remote locations around the world and can save lives by enabling a physician advice during health crisis. The system will incorporate MESH operation to work as a relay to transfer the data around the globe. The long-range radio transmission data will be private and secured including advanced error-correction protocol to ensure reliable and efficient communication channel. The system is also envisioned to provide the user’s location with or without GPS services. The company is targeting this system as a potential candidate for remote telemedicine, military rescue and health monitoring, maritime telemedicine, remote hiking and similar health support in faraway locations.

 

"Imagine a mountain climber somewhere in the Himalayas that encountered a health-related issue and needs an immediate physician consultation. Obviously, there are no conventional communication at this location and even a satellite phone can maintain near-continuous, delayed global coverage at times. With this system the climber will be able to take vitals using a qTerm device and sending the results to a physician in New York city in real-time. Since the technology is designed to be  bi-directional we envision the physician being able to advise on further steps to assist with the health emergency. In addition, a full audio communication can be established with the physician via this channel. " Stated Danny Rittman, the Company’s CTO.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.


Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

 

Wednesday, February 03, 2021

Investor Ideas #Potcasts 526, #Cannabis News and #Stocks on the Move; (TSX.V: $FLWR.V) (OTC: $FLWPF) (Nasdaq: $JAZZ) (Nasdaq: $GWPH) (NYSE: $MJ)

 

Investor Ideas #Potcasts 526, #Cannabis News and #Stocks on the Move; (TSX.V: $FLWR.V) (OTC: $FLWPF) (Nasdaq: $JAZZ) (Nasdaq: $GWPH) (NYSE: $MJ)

 


Delta, Kelowna, BC, February 3, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/020321-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/02031FLWR-JAZZ-GWPH-MJ.asp

 

Hear the investor ideas potcast on Spotify

                                           

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few public and private company announcements.

 

Dynaleo, Canada’s highest-capacity manufacturer of premium cannabis-infused soft chews, today announced the launch of two brands – Sunshower and DYNATHRIVE CBD. The two new brands are available in authorized retail locations and online channels in British Columbia and Saskatchewan, with plans to expand to Alberta, Ontario and additional regions in the near future.

 

Sunshower will launch with three delicious flavours (Watermelon Lemonade, Mango Tangerine, and Wild Strawberry) with each pack containing 5 pieces and 10 mg total THC. Sunshower is aimed at adults looking for an enjoyable and consistent THC experience with the finest flavours and ingredients. Inventory in Saskatchewan, the first province to place orders, has already sold out two shipments in its first month.

 

DYNATHRIVE CBD is Canada’s first and only large format CBD soft chew. Our first flavour, Apple Cider Vinegar, is made with purified CBD isolate, Canadian apple juice and real apple cider vinegar to deliver a sweetly refreshing, tart taste. The first DYNATHRIVE CBD format contains 30 pieces, perfect for daily supplements, with 300mg total CBD and is aimed at the growing segment of wellness consumers who are seeking a more enjoyable and convenient way to take CBD. The company has also formulated several additional flavours and unique product formats for launch later in 2021 to compliment these initial offerings.

 

“We continue to see accelerating demand in the edibles market for high-quality recreational and wellness cannabis products, especially from those who want to experience cannabis without needing to inhale. At the same time, consumers and retailers are experiencing inconsistent supply, both in terms of quantity and quality. As Canada’s highest-capacity soft chew manufacturer, we are in a unique position to have our products available at all times to consistently meet consumer demand with a best-in-class experience,” says Dynaleo Executive Chairman Michael Krestell.

 

Krestell continues, “In terms of the wellness consumer, countless customers have made it clear that they want CBD but without the intoxicating effects of THC. The 2- or 5-piece CBD offerings in the market today do not match up well for customers looking to take CBD on a daily basis or even throughout the day. The DYNATHRIVE CBD 30-piece pack is the perfect solution for them.”

 

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPFprovided commentary on the decision by INFARMED, I.P. (“INFARMED”), Portugal’s National Authority of Medicines and Health Products, to approve the first market authorization which will allow a licensed producer of medical cannabis to release products in Portugal.

 

“We applaud the decision by INFARMED, which was the first of its kind, to allow patients to have access to medical cannabis products in Portugal through indication-specific market authorizations. The Portuguese government is forward thinking in its approach to improving the quality of life for Portuguese patients as scientific data continues to mount regarding medical cannabis as both safe and efficacious in treating a variety of conditions,” commented Pauric Duffy, Flowr’s Managing Director of Europe. “This ground-breaking decision sets the stage for Flowr to pursue market authorizations to serve Portuguese and European patients with medical cannabis produced from our world class local facilities in Sintra and Aljustrel,” commented Lance Emanuel, President and Interim CEO of Flowr.

 

In March 2020, Flowr announced that its wholly-owned subsidiary in Europe, Holigen Holdings Limited (“Holigen”), received its Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its indoor manufacturing facility located in Sintra, Portugal. The GMP certification was issued by INFARMED. Holigen is in the process of conducting stability testing on certain of its high-THC genetics and expects results within 2021.

 

Located just outside of Lisbon, Holigen’s Sintra facility is a purpose-built facility with six grow rooms, a research and development lab and an expected extraction processing facility. The Sintra facility is capable of producing approximately 2,000 kilograms of premium dried flower when fully optimized. Holigen’s European operations also include the Aljustrel facility which has more than 5,000,000 square feet of outdoor grow space and greenhouse capacity, capable of producing in excess of 500,000 kilograms of cannabis when fully operational.

 

Tikun Olam Cannbit  (TASE:TKUN) reports that its international arm, Cannabit Ltd.will be the exclusive supplier of medical cannabis for clinical research into treatment for opioid addiction. The company will be entitled to exclusive marketing of the treatment method in Israel, Germany and England too.

 

The study will be done using a patent for an addiction treatment method that is currently undergoing registration by JFM Technology Holdings LLC, for which Opiostop has received an exclusive, unlimited license, under the U.S. FDA's fast-track.

 

The U.S. company Opiostop will provide all the financing, the submission of the patent and follow-up submissions, will be responsible for the performance and financing of the clinical trial in the United States, and will see to getting all the licenses for importing into the United States.

 

The treatment method may affect the market of opioid sales in the United States, which is estimated at about $20,000,000,000 (twenty billion dollars) per year.

 

After his daughter died as a result of opioid addiction, and his son also became addicted to analgesics, Jonah Rosenblatt, the founder of Opiostop, developed a special, three-stage method for withdrawal from opioids. The stages include, among other things, using approved drugs – synthetic and semisynthetic opioids – combined with treatment using medical cannabis.

 

Rosenblatt has already filed a patent for the method, and the company is now working on raising capital and starting clinical trials in the United States, with the intent of conducting clinical trials, submitting and approving the treatment through the FDA's fast-track.

 

Avinoam Sapir, the CEO of Tikun Olam-Cannabit states: "Rosenblatt's opioid method of treatment is on the FDA's fast-track for approval, in order to solve the problem of severe addiction to opioids that has been sweeping through the United States in recent years. Every 17 minutes, someone dies in the United States of an analgesic overdose. Tikun Olam–Cannabit is happy to be part of the possible solution to this severe 'plague' of analgesic addiction, a problem that can be identified here in Israel too."

 

Jonah Rosenblatt, the CEO of Opiostop states: "Over 70,000 Americans, and half a million people worldwide die each year from the Opioid Epidemic. This is ripping apart the fabric of society. We believe that combining our Multi-modal approach to curing addiction with CANNBIT'S Cannabinoid based medications & formulations. As the Clinical research of Medical Cannabis has been shown to reduce opioid dependency. By coming together in this JV, together we are extremely confident in our combined effort to reach our goal of giving people back their free will.”

 

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPHtoday announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration of $7.2 billion, or $6.7 billion net of GW cash. The transaction, which has been unanimously approved by the Boards of Directors of both companies, is expected to close in the second quarter of 2021.

Upon close of the transaction, the combined company will be a leader in neuroscience with a global commercial and operational footprint well positioned to maximize the value of its diversified portfolio.

 

GW is a global leader in discovering, developing, manufacturing and commercializing novel, regulatory approved therapeutics from its proprietary cannabinoid product platform to address a broad range of diseases. The company's lead product, Epidiolex® (cannabidiol) oral solution, is approved in patients one-year and older for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome and Tuberous Sclerosis Complex (TSC), all of which are rare diseases characterized by severe early-onset epilepsy. Epidiolex was the first plant-derived cannabinoid medicine ever approved by the U.S. Food and Drug Administration (FDA). This product has also been approved, under the tradename Epidyolex®, by the European Medicines Agency (EMA) in patients two years of age and older for the adjunctive treatment of seizures associated with LGS and Dravet syndrome in conjunction with clobazam and is under EMA review for the treatment of seizures associated with TSC. In addition to the approved indications for Epidiolex, there are considerable opportunities to pursue other indications within the epilepsy field, including other treatment-resistant epilepsies where significant unmet needs of patients exist.

 

Beyond Epidiolex, GW has a scientific platform and deep innovative pipeline of cannabinoid product candidates, as well as highly specialized manufacturing expertise, developed over two decades of pioneering and building leadership in cannabinoid science. This pipeline includes nabiximols, for which the company is in Phase 3 trials to seek FDA approval for treatment of spasticity associated with multiple sclerosis and spinal cord injury, as well as earlier-stage cannabinoid product candidates for autism and schizophrenia.

 

"Jazz is proud of our leadership position in sleep medicines and rapidly growing oncology business. We are excited to add GW's industry-leading cannabinoid platform, innovative pipeline and products, which will strengthen and broaden our neuroscience portfolio, further diversify our revenue and drive sustainable, long-term value creation opportunities," said Bruce Cozadd, chairman and CEO of Jazz Pharmaceuticals. "We are joining two teams that share a passion for, and track record of, developing differentiated therapies that advance science and transform the lives of patients. This will help facilitate a successful integration and bring added capabilities to Jazz. Given the strength of our balance sheet and the meaningful financial drivers of the transaction, we are confident in the value we can deliver to both companies' shareholders and patients. We look forward to welcoming the GW team to Jazz to build an even stronger company."

 

"Over the last two decades, GW has built an unparalleled global leadership position in cannabinoid science, including the successful launch of Epidiolex, a breakthrough product within the field of epilepsy, and a diverse and robust neuroscience pipeline. We believe that Jazz is an ideal growth partner that is committed to supporting our commercial efforts, as well as ongoing clinical and research programs," said Justin Gover, CEO of GW Pharmaceuticals. "We have a shared vision of developing and commercializing innovative medicines that address significant unmet needs in neuroscience and an approach of putting patients first. Together, we will have an opportunity to reach and impact more patients through a broader portfolio of neuroscience-focused therapies than ever before."

 

Jason Wilson, cannabis and banking expert at ETF Managers Group (NYSE: MJ) commented on this recent acquisition as well as the recent trends in the cannabis space saying “Jazz Pharma’s acquisition of GW Pharma, at a significant premium, demonstrates that pharmaceutical companies are recognizing the value and future potential of cannabinoid based medicines.  It is also another example that the cannabis industry is continuing to normalize and evolve beyond the traditional cultivation of flower, with potential well outside of our borders.  For investors, the acquisition of GW Pharma is another reminder that investing in cannabis touches many verticals globally, requiring a diverse approach beyond traditional cannabis cultivation companies.”

Mr Wilson continued to discuss some of the other factors behind the recent rally in cannabis stocks, such as “domestically, Senate Majority Leader Schumer has confirmed that cannabis reform legislation will be a key priority in the current Congress, and that it will include sensible tax and regulatory oversight at the federal level along with criminal justice reform; Globally, Mexico recently published its federal medical cannabis regulations, and the UN voted to remove medical cannabis from its list of dangerous narcotics. These recent catalysts occurred on the backdrop of strong global cannabis sales growth in 2020 (2020 global sales are expected to reach approximately $20 billion – an increase of approximately 35% versus 2019 sales of $15 billion) and suggest that the industry will continue to see strong growth and continued expansion domestically and globally for the foreseeable future. MJ’s diversified cannabis portfolio has benefitted from these recent global and domestic catalysts (up 90%+ in the previous three months, 40%+ YTD), and remains well positioned to take advantage of what is expected to be one of the fastest growing global industries over the next decade.”

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

Hear the investor ideas potcast on Spotify

                                           

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

#CryptoCorner #Podcast 521: #Stocks discussed: (NYSE: $V) (NasdaqGS: $OSTK)

 


#CryptoCorner #Podcast 521: #Stocks discussed: (NYSE: $V) (NasdaqGS: $OSTK)

 

Ether Hits New ATH, Visa Partners with First Boulevard, tZERO Signs #Tech Integration Agreement with Vertalo, Argo Reports Operational Results and Announces Share Purchase Agreement

 

 

Point Roberts, WA, Delta BC February 3, 2021 -  Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving cryptocurrency stocks and the crypto market.

 

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2021/020321-CryptoMarket.mp3

 

Read this in full at https://www.investorideas.com/news/2021/crypto-corner/02031V-OSTK.asp

 

Get the Crypto Corner Podcast on iTunes

 

Get the Crypto corner on Spotify

 

Stocks discussed: (NYSE:V) (NasdaqGS:OSTK) (LSE:ARB)

 

Bitcoin (BTC) has been gradually ascending over the past day or so and is trading, at press time, for about $36,570, according to data from CoinMarketCap. More notable, perhaps, is Ether (ETH), which has again set a new all-time high with a trading price of $1,550 at press time. Though Bitcoin is still comfortably the top cryptocurrency in terms of market cap and trading price, Ether has outperformed it so far this year by nearly doubling in value.

 

Visa (NYSE:V) has announced a partnership with First Boulevard, described in the press release as “a digitally native neobank focused on building generational wealth for the Black community.” The latter will pilot Visa’s new suite of crypto APIs, allowing “customers to purchase, custody and trade digital assets held by Anchorage, a federally chartered digital asset bank.” Jack Forestell, Chief Product Officer, Visa, explained:

 

"We set out to make Visa the bridge between digital currencies and our global network of 70 million merchants and today we are the leading network for crypto wallets with 35 crypto platforms choosing to issue with Visa. With this pilot program, we want to extend the value of Visa to our neobank and financial institution clients by providing an easy bridge to crypto assets and blockchain networks."

 

tZERO, the blockchain arm of Overstock.com (NasdaqGS:OSTK) has signed a technology integration agreement with digital transfer agent Vertalo. According to the press release, Vertalo “enables the issuance and management of compliant digital securities and connects broker-dealers, issuers, custodians, and exchanges through its B2B SaaS platform.” tZERO CEO Saum Noursalehi, commented:

 

"We are excited to integrate Vertalo into the tZERO ecosystem. Issuers that have tokenized with Vertalo will now have private digital securities compatible with our trading ecosystem, providing them a path to secondary liquidity."

 

Argo Blockchain (LSE:ARB) has reported operational results for January 2021, revealing that it mined 93 bitcoins during the month. The company also reports mining revenue of £2.48 million ($3.38 million USD), generated at an average monthly mining margin of approximately 71 percent for January. Additionally, Argo announced that its wholly-owned subsidiary, Argo Innovations Labs Inc., has signed a Share Purchase Agreement with Canadian data centre provider GPU.one, for the strategic purchase of the two data centres in Quebec. Boasting 20MW of power capacity, this “will provide Argo with long term stability and direct control over the facilities.” Argo’s CEO Peter Wall said:

 

"I am thrilled that Argo has delivered our best month in the company's history in both mining revenue and profits. The year has started off very strong. I'm also pleased we have signed the Share Purchase Agreement with GPU.one, an important step in us closing this transaction, and taking over those facilities ourselves."

 

Sam Mowers, Investorideas

 

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

 

 



Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories